HANQUYOU is the China-developed biosimilar with the most marketing approvals, covering 41 countries and regions The launch of HANQUYOU kicks off the competition between Chinese pharmaceutical companies and the world’s bio-pharmaceutical companies in biosimilar monoclonal antibodies…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.